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Introduction: Exercise induced laryngeal obstruction (EILO) is relatively common in
adolescents, with symptoms often confused with exercise induced asthma. EILO often
starts with medial or inward rotation of supraglottic structures of the larynx, whereas
glottic adduction appears as a secondary phenomenon in a majority. Therefore, surgical
treatment (supraglottoplasty) is used in thoroughly selected and highly motivated patients
with pronounced symptoms and severe supraglottic collapse.
Aim: To investigate efficacy and safety of laser supraglottoplasty as treatment for severe
supraglottic EILO by retrospective chart reviews.
Methods: The EILO register at Haukeland University Hospital, Bergen, Norway
was used to identify patients who had undergone laser supraglottoplasty for severe
supraglottic EILO, verified by continuous laryngoscopy exercise (CLE) test, during
2013–2015. Laser incision in both aryepiglottic folds anterior to the cuneiform tubercles
and removal of the mucosa around the top was performed in general anesthesia.
Outcomes were questionnaire based self-reported symptoms, and laryngeal obstruction
scored according to a defined scheme during a CLE-test performed before and
after surgery.
Results: Forty-five of 65 eligible patients, mean age 15.9 years, were included.
Post-operatively, 38/45 (84%) patients reported less symptoms, whereas CLE-test
scores had improved in all, of whom 16/45 (36%) had no signs of obstruction. Most
improvements were at the supraglottic level, but 21/45 (47%) also improved at the
glottic level. Two of 65 patients had complications; self-limiting vocal fold paresis and
scarring/shortening of plica ary-epiglottica.
Conclusion: Supraglottoplasty improves symptoms and decreases laryngeal
obstruction in patients with severe supraglottic EILO, and appears safe in
highly selected cases.
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INTRODUCTION
Exercise induced laryngeal obstruction (EILO) is relatively
common in young individuals (1–5). Symptoms are primarily
prolonged and/or noisy inspiration and shortness of breath
during ongoing high intensity exercise (6). Continuous
laryngoscopy exercise test (CLE-test) (7) visualize the
progression of obstruction during ongoing exercise from
start to exhaustion, being essential for proper diagnosis
and for subsequent planning and choice of treatment (8–
11). Typically, the larynx appears endoscopically normal
at rest whereas a transient, reversible narrowing occurs as
exercise intensity increases. EILO is increasingly recognized
as an important differential diagnosis to exercise-induced
asthma/bronchoconstriction (EIB) in otherwise healthy
adolescents (6, 10, 12–15).
Multiple treatment options are being applied for EILO,
including surgical and non-surgical approaches, but so far
none are based on high-quality evidence (2, 4, 10, 16). The
etiology of EILO is likely to be heterogeneous, and at least
two distinct phenotypes have been suggested; one characterized
predominantly by a supraglottic medialization and/or collapse
that clearly precedes the glottic obstruction, and another
phenotype in which the glottic obstruction seems to incite the
sequence of events (5, 6, 17). Treatment must be individualized
and take into account these diverse findings (10). In a clinical
setting, the role of surgery should be secondary to conservative
treatment, such as properly guided breathing advice, speech
therapy or inspiratory muscle training (4, 18–25). The literature
suggests that surgery is beneficial in patients with a clearly
predominant supraglottic involvement for whom EILO represent
a significant clinical problem (4, 10, 11, 26). Follow-up studies for
up to 5 years suggest lasting positive results (27, 28).
Surgery in patients with EILO is being performed at several
centers, but a literature review revealed that results from only 72
cases have been published (26, 29). In this retrospective study,
we investigated the efficacy and safety of laser supraglottoplasty
for supraglottic EILO performed at our hospital, with CLE tests
performed before and after surgery in all.
MATERIALS AND METHODS
Participants and Study Design
This study was based on a retrospective review of the EILO-
register at Haukeland University Hospital, Norway. Our unit
receives patients with suspected EILO from all Norway, and
annually performs∼250 CLE tests. Patients who had been treated
surgically with supraglottoplasty for EILO on clinical indications
during 2013–2015 were included. First-line therapy for EILO at
our institution (received by all patients) was physician-guided
Abbreviations: CLE-test, continuous laryngoscopy exercise test; EIB, exercise-
induced asthma/bronchoconstriction; EIIS, exercise induced inspiratory
symptoms; EILO, exercise induced laryngeal obstruction; FEV1, forced
expiratory volume in first second; IMT, inspiratory muscle training; NRS,
numeric rating scale; PCA-muscle, posterior cricoarytenoideus muscle; Pimax,
maximal inspiratory mouth pressure; VAS, visual analog scale; VCD, vocal
cord dysfunction.
structured breathing advice while patients were observing their
laryngeal responses on the monitor (biofeedback). Second-
line treatment options were speech therapy or physician-
guided inspiratory muscle training (IMT), with supraglottoplasty
reserved for highly selected supraglottic cases. Indication for
supraglottoplasty was based on symptom severity, the extent
of the supraglottic collapse during a CLE-test (7), and patient
motivation. Patients with laryngomalacia characteristics at rest
[omega-shaped/juvenile epiglottis and prominent cuneiform
tubercula’s and/or redundant mucosa at the arytenoid region
(30)], were excluded. Co-existing asthma had been treated
according to guidelines (31), and asthma had been excluded as
the cause of the patients’ symptoms by a clinical interview and if
in doubt, by performing spirometry after an exercise test (32). All
patients had been informed about the surgical procedure and of
risk factors.
The study was approved by the Committee on Medical
Research Ethics of Western Norway (REK number 2016/1898),
and informed written consent was obtained from the participants
and/or their guardian.
Subjective Symptom Scores
Symptom scores before and after surgery were obtained using
a questionnaire that also included demographic background
variables. All patients answered these four questions (Q):
Q1. “Have your symptoms improved after the previous test?”,
“yes”/“no”; Q2. “Rate your breathing problem on a scale from 0
to 10”; Q3. “I experience inspiratory breathing difficulty when I
exercise,” using a numeric rating scale (NRS) from 1 to 5 (1 =
never, 2 = sometimes, 3 = often, 4 = almost every time, 5 =
always); Q4. “When you are physically active, how much are you
bothered by your breathing difficulties?”, using NRS from 1 to
5 (1 = nothing, 2 = a bit, 3 = pretty much, 4 = a lot, and 5
= disabling).
Spirometry and CLE-Test
Spirometry was performed with a Vmax 22© spirometer
(SensorMedics, Yorba Linda, CA, USA) according to guidelines
(33). A trans-nasal flexible fiberoptic laryngoscope (Olympus
ENF-P3©, Tokyo, Japan), diameter 3.5mm, introduced after
applying a decongestive nasal spray (Rhinox©) and local
anesthesia (Xylocaine©), was secured using a custom designed
helmet in a position allowing for a good view of supraglottic
structures and the vocal folds. Maximum voluntary ventilation
(MVV) and ergospirometry data were collected in conjunction
with the CLE-test using a Jaeger Oxycon Pro Cardiopulmonary
Exercise testing system (Viasys Health Care, Yorba Linda,
CA, USA). Continuous video-recorded laryngoscopy throughout
a maximal cardiopulmonary exercise test on a treadmill
(Woodway ELG 70, Weil am Rhein, Germany) was performed as
previously described (the CLE-test) (7) before and after surgery.
Simultaneous a computerized and modified Bruce ramp protocol
coupled with integrated video-recording of the upper part of
the body and sound-recordings was performed. The treadmill
protocol increased speed and/or elevation every 1min, aiming
to reach maximum exercise capacity after 6–14min (34). The
test was considered successful if the patient continued until
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exhaustion or was stopped by respiratory distress, preferably
supported by a plateau in oxygen consumption and/or heart
rate response.
Evaluation of CLE-Test
Laryngeal movements were scored as previously described at
moderate and maximum exercise intensity, both at the glottic
and supraglottic level (Figure 1) (2, 35). The assessments were
done retrospectively, using the stored video-recorded CLE-tests
presented in pairs (pre-post) to four experienced raters (HHC,
ODR, MH and JHH). A blinded procedure was tested but proved
impossible, as the surgical changes were impossible to hide. Thus,
assessments were open and consensus-based. A score of ≥2 at
either glottic or supraglottic level was interpreted as abnormal.
Supraglottic EILO was defined by the supraglottic obstruction
preceding the glottic obstruction and supraglottic (D) scores >
glottic (C) scores at maximum exercise. Patients referred for
supraglottoplasty had a supraglottic score ≥2, except one patient
included because of large involvement from a retroflex epiglottis.
Obstruction of the vocal folds (i.e., the glottic level) was not
an exclusion criterion, but the supraglottic adduction should
be the inciting event and clearly the predominant element of
the obstruction.
Supraglottoplasty
All patients underwent surgery in general anesthesia
with suspension micro-laryngoscopy and endoscopic
supraglottoplasty with carbon dioxide laser, performed by
one of two surgeons, experienced with laryngoplasty. The
oral laser endotracheal (LET) tube was positioned posteriorly,
protecting the interarytenoid area. A Lindholm/Benjamin
laryngoscope was introduced into the vallecular exposing both
aryepiglottic folds and epiglottis. The arytenoid was grasped
with micro laryngeal forceps and pulled slightly forward and
medially stretching the aryepiglottic fold, revealing the amount of
abundant arytenoid tissue. Laser beams of 2–4Watt focused with
micro spot was utilized. The aryepiglottic fold was split anteriorly
down to the level of the musculus aryepiglotticus approaching
the cranial margin of plica ventricularis. Then tissue around the
top of the cuneiform cartilages was removed in a circular pattern,
creating a triangular shaped excision (Figure 2). In cases where
the cuneiform tubercles were pointy and exposed in the excision,
parts of this cartilage were included. The same procedure was
performed bilaterally making sure to avoid endothelial damage
to the interarytenoid covered by the LET-tube. In some cases
with epiglottic involvement, epiglottotomy and rotation of
the epiglottis toward the tongue base (epiglottopexy) were
performed. Specific anatomic decisions tailored to the individual
patient’s anatomy were guided by findings on preoperative
video-recording during CLE-test (26, 27, 36).
Statistical Methods
This was a cross-sectional pre-post study, with main outcomes
being CLE-scores and symptom scores obtained before vs. after
surgery, compared with Student’s paired t-test. The CLE-scores
are by nature ordinal and categorical, ranging from 0 to 3.
Due to the few number of categories, data were calculated and
reported as mean values with 95% confidence intervals (CI), as
this is considered to provide more information than medians
and interquartile ranges (37). To account for multiple correlated
measurements in the same test subjects, mixed linear regression
with fixed effects including three-way and two-way interactions
was applied to address CLE-score changes before vs. after surgery
obtained at moderate vs. maximal exercise intensity and at glottic
vs. supraglottic laryngeal levels (38). All analyses were performed
with SPSS version 24 (SPSS, Chicago, IL, USA).
RESULTS
Sixty-five patients were eligible during the inclusion period.
Twelve patients were excluded due to incomplete datasets,
either pre- CLE-test or post-CLE-test, four patients did not
consent to participation in the study and four patients were
excluded retrospectively due to laryngeal findings characteristic
of laryngomalacia. Thus, 45 patients were included; age 10–
25 (mean 15.9) years, 14 males and 31 females. Baseline
characteristics are outlined in Table 1. The post CLE-test was
performed between 4 and 28 months (mean 13.4 months) after
surgery. Lung function, distance completed on treadmill, minute
ventilation (VE), peak VO2 (ml/min) and maximal heart rate
did not differ before vs. after surgery. MVV had increased
significantly after surgery, and respiratory rate at peak exercise
was reduced (Table 2). Epiglottotomy and/or epiglottopexy were
performed as additional surgery in five of the 45 patients. As the
CLE scoring system does not encompass ways to assess this type
of surgery, these outcomes were not tabulated.
Subjective Symptom Scores
One patient did not complete the post-test questionnaire, for
unknown reason. After surgery, perceived subjective symptoms
improved in 38/44 (86%), were unchanged in 5/44 (11%),
whereas 1/44 (2%) were unsure. The responses to the questions
Q2, Q3 and Q4 improved significantly, and 25/43 (58%) patients
(one did not answer this question) responded nothing or a bit to
question Q4 (When you are physically active, how much are you
bothered by your breathing difficulties after surgery?) (Table 3).
Two patients reported more symptoms after surgery; one of
whom had a post-operative complication.
Laryngeal Findings During Exercise
(CLE-Score) and Complications
Laryngoscopy at rest was normal in all subjects. All patients
had significantly lower CLE-scores after surgery, with sum-score
(E) significantly reduced from 5.38 to 2.36; most improvements
explained by reduced supraglottic scores at maximum exercise
(CLED-score) (Table 4 and Figure 3). After surgery, 16/45 (36%)
patients had no signs of laryngeal obstruction at maximum
exercise intensity, i.e., CLE sum-score 0 or 1 (Figure 4). In
38/45 (84%) patients, CLE sum-score was reduced by 2 or
more, reductions mainly occurring at the supraglottic level,
as expected. However, in 21/45 also the glottic obstruction
decreased at maximum intensity exercise, 10 of whom with
a reduction of the glottic score of ≥2. In one patient, only
the glottic obstruction improved, reducing CLE C-score (glottic
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FIGURE 1 | Grading system of laryngeal obstruction according to Maat et al. (35), reproduced with permission.
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FIGURE 2 | Supraglottoplasty with carbon dioxide laser on a patient with
exercise induced laryngeal obstruction (EILO). Laser beams of 2–4 Watt
focused with micro spot was utilized. The aryepiglottic fold was split anteriorly
down to the level of the musculus aryepiglotticus approaching the cranial
margin of plica ventricularis. Then tissue around the top of the cuneiform
cartilages was removed in a circular pattern, creating a triangular shaped
excision.
TABLE 1 | Baseline characteristics of the 45 patients included from the EILO
register at Haukeland University Hospital, Bergen (Norway) who were surgically
treated for EILO during 2013–2015.
Variable category Pre-operative Post-operative P-valuea
Female, n (% of group) 31/45 (68.9)
Age in years, mean (range) 15.9 (10–25) 16.6 (11–27)
Height in cm, mean (SD) 166.2 (10.3) 168.89 (9.4) <0.001
Weight in kg, mean (SD) 57.7 (11.1) 62.21 (12.2) <0.001
LUNGFUNCTION
FVC, % of predicted (SD) 104.8 (14.1) 104.3 (14.7) 0.667
FEV1, % of predicted (SD) 106.2 (13.1) 104.7 (13.5) 0.285
FEV1/FIV1 or FEF50/FIF50 > 1.5 2 (4.4) 2 (4.4)
TREATMENT BEFORE SURGERY, n (%)
First line conservative therapy only 30 (66.7)
Second line therapy
IMT 14 (31.1)
Speech therapy 1 (2.2)
LEVEL OF LARYNGEAL OBSTRUCTION, n (%)
Only supraglottic 4 (9.1)
Supraglottic ≥2 and glottic =1 22 (50.0)*
Supraglottic ≥2 and glottic ≥2 18 (40.9)
Values are ratios (% of group) or means (SD).
aFrom Student’s paired t-test.
EILO, exercise induced laryngeal obstruction; IMT, inspiratory muscle training; FVC, forced
vital capacity; FEV1, forced expiratory volume in first second time; FEF50, forced expiratory
flow at 50%; FIF50, forced inspiratory flow at 50%; SD, standard deviation.
*One patient with supraglottic score 1 and glottic score 1 was included because of large
involvement from a retroflex epiglottis (not assessed in the scoring system).
TABLE 2 | Ergospirometry data of the 45 patients included from the EILO register
at Haukeland University Hospital, Bergen (Norway) who were surgically treated for
EILO during 2013–2015.
Measuresa Pre-operative Post-operative p-valueb
Distance on treadmill; m 677 (607, 748) 680 (623, 738) 0.858
Heart rate; per min 184 (180, 189) 177 (165, 189) 0.200
VO2 max; ml/min 2760 (2,540, 2,979) 2822 (2,593, 3,051) 0.240
VO2 max; ml/kg/min 47.9 (45, 51) 45.4 (43, 48) 0.003*
Breathing frequency; per min 49 (45, 53) 44 (42, 47) 0.005*
Minute ventilation; liters 92.0 (84, 100) 94.7 (86, 103) 0.340
MVV; liters/min 109 (99, 108) 120 (111, 129) <0.001*
RER 1.16 (1.13, 1.19) 1.19 (1.15, 1.22) 0.079
Height; cm 166 (163, 169) 169 (166, 172) <0.001*
Weight; kg 57.7 (54, 61) 62.2 (59, 66) <0.001*
EILO, exercise induced laryngeal obstruction; VO2 max, maximal oxygen consumption;
MVV, maximal minute ventilation; RER, respiratory exchange ratio; CI, confidence interval.
aAll values are given as means (95% CI) at peak exercise.
bPaired sample t-test compare findings pre-operative vs. post-operative, *p ≤ 0.05.
TABLE 3 | Symptom scores based on four questions from the 45 patients
included from the EILO register at the Haukeland University Hospital, Bergen
(Norway) who were surgically treated for EILO during 2013–2015.
Questiona Pre-operative Post-operative p-valueb
Q1. “Has your symptoms improved




Q2. Rate your breathing problems
(NRS-scale from 0 to 10): mean
(95% CI)
7.4 (6.8, 8.1) 2.8 (1.9, 3.6) <0.001*
Q3a. “I experience inspiratory
breathing difficulty when I exercise?”
(NRS 0–5): mean (95% CI)
4.2 (3.9, 4.6) 2.6 (2.1, 3.0) <0.001*
Q4a. “How much are you bothered
by your breathing difficulties” (NRS
0–5): mean (95% CI)
3.8 (3.5, 4.2) 1.7 (1.4, 2.1) <0.001*
EILO, exercise induced laryngeal obstruction; NRS, numeric rating scale (0–10); CI,
confidence interval.
†
One patient did not answer the question.
aAnswer options: 1 = never, 2 = sometimes, 3 = Often, 4 = Almost every time, 5
= Always.
bp-Value from student paired t-test.
*p ≤ 0.05.
score at maximum exercise) from 3 to 1. In two patients, the
glottic obstruction worsened after surgery, but due to reduced
supraglottic obstruction, the overall sum-score was reduced. One
of these two had pre-operative glottic obstruction already at
moderate intensity exercise, while the other was one of the two
who experienced a post-operative complication.
In themixed linear regressionmodel the three-way interaction
was not significant (p = 0.231), neither was the two-way
interaction between exercise intensity (moderate vs. maximum)
and level of obstruction (glottic vs. supraglottic) (p= 0.232). The
final model included interactions between pre- vs. post-operative
and moderate vs. maximum exercise intensity, and pre- vs.
post-operative and glottic vs. supraglottic obstruction (both
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TABLE 4 | Continuous laryngoscopy exercise (CLE) scores from the 45 patients
included from the EILO register at Haukeland University Hospital, Bergen (Norway)
who were surgically treated for EILO during 2013–2015a.
CLE conditions Pre-operative Post-operative Pre-post change
Mean (SD) Mean (SD) Mean (SD) 95% CI
MODERATE INTENSITY
Glottic (CLE A) 0.27 (0.49) 0.09 (0.36) 0.18 (0.44) (−0.08, 0.43)
Supraglottic (CLE B) 1.18 (0.96) 0.49 (0.73) 0.69 (0.73) (0.43, 0.94)
MAXIMUM INTENSITY
Glottic (CLE C) 1.51 (0.92) 0.84 (0.93) 0.67 (0.93) (0.41, 0.92)
Supraglottic (CLE D) 2.42 (0.54) 0.93 (0.78) 1.49 (0.81) (1.23, 1.74)
Sum score (CLE E) 5.38 (2.07) 2.36 (1.85) 3.02 (1.60) (2.54, 3.50)b
CLE A, glottic obstruction at moderate intensity; CLE B, supraglottic obstruction at
moderate intensity; CLE C, glottic obstruction at maximum intensity; CLE D, supraglottic
obstruction at maximum intensity; CLE E, sum-score (A + B + C + D), see Figure 1 for
illustrations on CLE score; CI, confidence interval; SD, standard deviation.
a In the final mixed linear regression model: CLE-score= constant+ surgery+ Intensity+
location+ surgery*Intensity+ surgery*location, where all included effects were significant
(p < 0.001).
bEstimates from Student’s paired t-test, p < 0.001.
p-values < 0.001). Thus, the CLE-score change after surgery was
larger at maximum than at moderate exercise intensity, both
glottic and supraglottic. Moreover, the CLE-score change after
surgery was larger at the supraglottic than at the glottic level,
regardless of exercise intensity.
Post-operative complications occurred in one of the included
patients; a left vocal fold paresis that spontaneously resolved 3
years later. One of the 16 patients excluded due to missing pre-
operative data, experienced post-operative scarring. This patient
did not report post-operative breathing difficulties during daily
activities, but persistent respiratory symptoms during exercise.
This patient was offered a re-operation but declined. Hence,
correct complication rate in our data was 3% (2/65).
Conservative Treatment
Second-line conservative treatment had been attempted in only
15/45 patients since no gold standard for EILO-treatment exist.
Surgery was offered as a second or third-line option due to
persistent symptoms and supraglottic obstruction. Fourteen
patients underwent 6 weeks of inspiratory muscle training,
whereas one underwent speech therapy over several weeks. The
conservative treatment improved symptom scores (Q2) by 1.42
(p = 0.027), but patients perceived improvements as insufficient
and their CLE-scores did not alter.
DISCUSSION
In this retrospective review of patients treated with laser
supraglottoplasty for EILO, 86% reported perceived subjective
symptom improvement. The CLE-sum score decreased in all
patients; as expected most evident at the supraglottic level,
but notably, there were also significant improvements at the
glottic level. Our supraglottic findings are comparable to findings
in previous studies (9, 27, 28, 36), thus supporting that laser
supraglottoplasty is an efficient treatment in severe supraglottic
EILO. The favorable glottic response from surgery was a novel
finding. The study underlines the heterogeneity of EILO, and the
importance of thorough phenotyping before making a treatment
plan. Complications were rare.
Strength and Weakness
Our institution has performed more than 3,000 CLE-tests over
a period of 15 years, with surgery performed in 3%. We have
previously reported on 23 cases treated surgically for supraglottic
EILO, not included in this study (27). This present case series
is the largest published to date. It was a major strength that
post-operative CLE-tests were used to assess outcome in all
participants, contrasting some previous studies (9, 26–28, 39).
Evaluations based on subjective patient reports are vulnerable
to bias in both directions. There may be a positive placebo
effect induced by the surgical procedure per se. On the other
hand, patients can be disappointed that surgery treats only
their EILO and not their physical capacity, as evident in this
present study with virtually no changes in maximum oxygen
consumption. Validity and reliability of the CLE scoring system
varies somewhat between studies (28, 35, 40, 41); however, it
seems reasonable to conclude that experience is a factor that
influences these issues. In our study, four highly skilled raters
scored the videos based on a consensus system, much like how
CLE-tests are scored in everyday work. It has been suggested
that familiarity with the test situation should somehow by itself
improve the CLE-score; however, one third of our patients had
tried additional conservative treatment before surgery with no
significant reduction in CLE-scores with repeated tests. Similar
maximum heart rate, minute volume and running distance at
the pre-operative and post-operative CLE-test verified that the
intensity was similar and that the laryngeal findings therefore
could be compared.
Patients with EILO usually show normal supraglottic
anatomy and laryngeal motion at rest and may show supraglottic
appearance similar to laryngomalacia during exercise. Hence,
Bent et al. labeled their observations “exercise induced
laryngomalacia” (42). In order to avoid a mix between the
adult type of laryngomalacia and EILO we chose to exclude four
patients that had characteristics of laryngomalacia at rest (30).
All four reported improvements of symptoms, and their mean
CLE-sum scores improved substantially by 3.0 (data not shown).
An obvious weakness of this study was its retrospective design,
with patients allocated to surgery based on clinical decisions, with
no randomization, no blinding, and inconsistent follow-up times.
Supraglottoplasty as Treatment for EILO
Smith et al. first described endoscopic laser supraglottoplasty for
supraglottic EILO in 1995 (43). A systematic review based on
72 patients suggested that the procedure is safe and indicates
a favorable clinical response (29). In some published studies,
it is difficult to verify the specific technique used (29). Careful
assessment of our post-operative CLE-test files suggests that in
some cases, more of the redundant supraglottic tissue could
have been removed. On the other hand, a careful approach
is required when performing surgery in otherwise healthy
adolescents, particularly as long-term effects from surgery are
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FIGURE 3 | Mean CLE sub scores and sum score (E) with 95% CIs at glottic (A + C) and supraglottic (B + D) level, and at moderate and at maximum intensity
before and after supraglottoplasty from 45 patients included from the EILO register at Haukeland University Hospital, Bergen (Norway) who were treated with
supraglottoplasty during 2013–2015. CLE, continuous laryngoscopy exercise test; EILO, exercise induced laryngeal obstruction; CI, confidence interval. See Figure 1
for illustrations on CLE score (laryngeal obstruction scores).
FIGURE 4 | Laryngoscopic findings in a patient with exercise-induced laryngeal obstruction (EILO), both supraglottic and glottic obstruction during maximum exercise
intensity before (A) endoscopic supraglottoplasty and open laryngeal inlet after (B) endoscopic supraglottoplasty. Regarding CLE-scores, see Figure 1 for illustrations.
unknown, and as normal laryngeal function during high-
intensity exercise is poorly described (44). Also, the natural
course of EILO is unknown. Laryngeal structures are described
to become more rigid with age, and thus perhaps more stable
(45–47). Patients in rapid growth should probably primarily be
offered conservative treatment (10). A follow-up study up to 5
years showed persistent laryngeal obstruction during exercise in
patients treated conservatively, despite decreasing self-reported
symptoms (27). Symptomatic improvement could have been
related to reduced physical activity with age, challenging the idea
that EILO improves spontaneously with age (48, 49).
Post-operative Complications
Complications following supraglottoplasty for EILO have not
been reported, possibly as few post-operative CLE-tests have
been performed. Two studies have reported post-operative
symptomatic complaints; one reporting dysphagia (9), and
another breathing difficulties while exercising in cold air (27).
In the present study, one participant experienced a self-limiting
left vocal fold paresis, first believed to be due to luxation
of the arytenoid cartilage inflicted by the intubation tube.
However, extensive work-up revealed an Epstein-Barr viral
infection and a large mediastinal thymus, possibly affecting the
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recurrent laryngeal nerve. Examination 3 years later showed
normalized vocal fold movements and an open laryngeal inlet
during exercise (CLE sum-score 0). Another patient excluded
from participation as the pre-operative CLE-test could not
be scored, had laryngeal scarring in the post-operative CLE-
test. Previous laryngoscopies at rest revealed a laryngeal cyst,
a condition that empirically is known to increase the risk
for scarring. Patients with EILO are otherwise healthy young
people, and therefore complication rates should be close
to zero with potential gains carefully weighed against the
risks (10, 26).
Glottic Adduction
It has been stated that glottic closure is likely to be unresponsive
to surgical treatment (16). However, we found significant
improvements also at the glottic laryngeal level. We cannot easily
explain this, but perhaps the Bernoulli’s principle is involved;
i.e., removal of redundant supraglottic tissue leads to a wider
supraglottic entrance, possibly reducing airflow turbulence and
thus less negative luminal pressure, and therefore less adduction
of the vocal folds below. The recently published method for
measuring trans-laryngeal resistance appears as a promising
possibility for an objective numeric outcome that might shed
light on these issues (50).
CONCLUSION
Supraglottoplasty improves symptoms and reduces laryngeal
obstruction in patients with a predominant supraglottic EILO,
and appears safe and efficient in highly selected severe
cases. Notably, supraglottoplasty might improve also glottic
obstruction in patients with combined supraglottic and glottic
obstruction. Our findings substantiate the heterogeneity of EILO,
with phenotypes that require different treatment approaches.
Risk of complications calls for careful selection of patients based
on a multidisciplinary approach, with conservative treatment
carefully tested prior to surgery. There is an urgent need for
randomized studies and longer follow-up periods.
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